MOH
- Marketing authorisation holder: SYNDAX
- Status: likely_approved
🇮🇱 Revuforj in Israel
Revuforj (REVUMENIB) regulatory status in Israel.
Marketing authorisation
Revuforj in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Revuforj approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Revuforj in Israel?
SYNDAX holds the Israeli marketing authorisation.